Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px
Document › Details

Novo Holdings A/S. (6/23/17). "Press Release: Novo A/S Renamed Novo Holdings A/S".

Organisations Organisation Novo A/S
  Today Novo Holdings A/S
  Group Novo Group (Group)
  Organisation 2 Novo Holdings A/S
  Group Novo Group (Group)
Products Product venture capital
Person Person Mostrup Scheel, Christian (Novo Group 201706 Senior Press OFficer of Novo Holdings A/S)

Novo A/S, the holding company for the companies in the Novo Group, is changing its name to Novo Holdings A/S.

The new name will more accurately reflect the company’s role and will help to reduce any confusion with the other companies in the Novo Group.

In connection with the new name, Novo Holdings will add the tagline “Investors in life science”. This clarifies that the company is a life-science focused investor, in addition to being the holding company of the Novo Group.

Novo Holdings currently wholly or partly owns more than 80 life-science companies, many of which are headquartered in the United States. Last year, the company invested DKK 8.7 billion in the life sciences. The strategy of Novo Holdings is to substantially increase its investments in life-science companies over the coming years.

Kasim Kutay, CEO of Novo Holdings, says: “The new name and tagline give Novo Holdings a more distinct profile and is in line with our strategy to become recognized as one of the world’s leading investors in life science, with a focus on longterm value creation.”

About Novo Holdings
Novo Holdings is a private limited liability company wholly owned by the Novo Nordisk Foundation.

The company is the holding company in the Novo Group, comprising Novo Nordisk A/S, Novozymes A/S and NNIT A/S, and is responsible for managing the Foundation’s assets.

In addition to being the major shareholder in the Novo Group companies, Novo Holdings provides seed and venture capital to development-stage companies, takes significant ownership positions in well-established companies within life science and manages a broad portfolio of financial assets. Read more at

About the Novo Nordisk Foundation

The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. The Foundation has two objectives: 1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group; and 2) to support scientific, humanitarian and social causes.

The vision of the Foundation is to contribute significantly to research and development that improves the health and welfare of people. Since 2010, the Foundation has donated more than DKK 10 billion (€1.3 billion), primarily for research at public institutions and hospitals in Denmark and the other Nordic countries. Read more at

Further information

Christian Mostrup Scheel, Senior Press Officer,, +45 3067 4805

Christian Mostrup Scheel
Senior Press Officer
Mobile: +45 3067 4810

Novo Holdings A/S
Tuborg Havnevej 19
DK–2900 Hellerup
+45 3527 6500
CVR no 24 25 76 30

Record changed: 2023-06-05


Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x200px

More documents for Novo Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2023 Munich BEU23 650x300px

» top